Impact acceleration accounts (IAAs) are strategic awards providing funding to research organisations to use creatively for a wide range of impact activities.
The aim of this programme is to speed up the transition from discovery research to translational development projects. It will do this by funding preliminary work to establish whether an approach or technology is viable and to rapidly de-risk projects across the whole translational pathway.
Following the harmonisation of UKRI Impact Acceleration Accounts, MRC’s Confidence in Concept has now become MRC Impact Acceleration Accounts (IAA).
IAA is an integral part of MRC’s translational research strategy and provides annual awards to institutions of between £100,000 and £750,000 to flexibly support a portfolio of translational research projects and activities. It is intended to accelerate the transition from discovery research to translational development projects by supporting preliminary work to establish the viability of an approach and to rapidly de-risk projects across the whole translational pathway so that they become competitive for substantial funding for development.
Since 2012, MRC has invested over £152 million in the scheme. It has funded 43 research institutions across the UK and supported over 2000 projects and activities. These projects have generated proof-of-concept data, secured follow-on funds for further development, and led to new industry collaborations and spin-out companies.
The current round of IAA awards ends on 31 March 2026.
Ensuring that fundamental science is translated into new therapies, diagnostics and medical devices is central to our mission. MRC’s IAA aims to accelerate the transition from discovery science to the early stages of therapeutic and biomarker development and rapidly de-risk projects across the translational lifecycle, so that they become competitive for substantial funding.
The award provides institutions with locally administered, flexible funding to support a diverse portfolio of translational projects and activities, and to respond to institutional needs and opportunities. The projects supported should aim to generate sufficient or critical preliminary data to establish the viability of an approach before seeking more substantial funding, for example, from the Developmental Pathway Funding Scheme (DPFS).
The funding is not intended to support:
Collaborative working and cross-sector skills flow are often key to successful translational development. Institutions are encouraged to explore how awards could be used to develop new academic and industry interactions and enable knowledge exchange, and may use a small proportion (up to 15%) of the award to support such activities. These can include networking and showcase events, developing early stage collaborations, supporting short-term people exchanges and co-funding projects.
Find guidance on MRC Industry Collaboration Framework (ICF).
Email: dpfsanddcs@mrc.ukri.org
Email: sophie.liddell@mrc.ukri.org
See a list of all UKRI IAAs.
Questions about accessing IAA funding at a particular organisation should be directed to that organisation.
Last updated: 26 September 2024
